Understanding The Role of MMRN2 in Disease (G79812)

Target Name: MMRN2

NCBI ID: G79812

MMRN2

Understanding The Role of MMRN2 in Disease

MMRN2 (EMILIN-3) is a gene that encodes a non-coding RNA molecule that has been shown to play a role in the development and progression of various diseases, including cancer. The molecule is also of interest as a potential drug target or biomarker , due to its potential to intervene in the development and progression of these diseases.

MMRN2 is a microRNA (miRNA) that is expressed in a variety of tissues and cells throughout the body. It is typically expressed at low levels in tissues such as muscle, pancreas, and placenta, but can also be found at higher levels in other tissues such as the brain and heart.

The function of MMRN2 is not well understood, but it is known to play a role in the regulation of gene expression. miRNAs are small non-coding RNAs that can interact with target genes to either activate or repress their expression. This interaction between miRNAs and target genes is critical for the regulation of gene expression and is a crucial aspect of gene function.

MMRN2 has been shown to play a role in the regulation of gene expression in various tissues and cells. For example, studies have shown that MMRN2 can repress the expression of genes involved in cell adhesion, migration, and invasion, which are critical processes that are involved in the development and progression of many diseases, including cancer.

In addition to its role in gene regulation, MMRN2 has also been shown to play a role in the development and progression of certain diseases. For example, studies have shown that high levels of MMRN2 expression are associated with the development of certain types of cancer, including breast, ovarian, and prostate cancer. Additionally, MMRN2 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of diseases such as neurodegenerative disorders, diseases of the immune system, and diseases of the respiratory system.

As a potential drug target, MMRN2 is of interest due to its ability to interact with a variety of targets and to play a role in the regulation of gene expression. This makes it a promising candidate for intervention in a variety of diseases. For example, MMRN2 has also been shown to interact with targets involved in cell adhesion, migration, and invasion, which are involved in the development and progression of many diseases, including cancer. Additionally, MMRN2 has also been shown to interact with targets involved in the regulation of cellular processes that are important for the development and progression of diseases such as neurodegenerative disorders, diseases of the immune system, and diseases of the respiratory system.

In conclusion, MMRN2 is a gene that encodes a non-coding RNA molecule that has been shown to play a role in the development and progression of various diseases, including cancer. Its function is not well understood, but it is known to play a role in the regulation of gene expression. As a potential drug target or biomarker, MMRN2 is of interest due to its ability to interact with a variety of targets and to play a role in the regulation of gene expression. Further research is needed to fully understand the role of MMRN2 in disease and its potential as a drug target or biomarker.

Protein Name: Multimerin 2

Functions: Inhibits endothelial cells motility and acts as a negative regulator of angiogenesis; it down-regulates KDR activation by binding VEGFA

The "MMRN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMRN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets